Tumor lymphangiogenesis and lymphangiogenic growth factors.
about
Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tractThe role of lymphangiogenesis and angiogenesis in tumor metastasisExpression of MACC1 and c-Met in human gastric cancer and its clinical significance.Lymphangiogenesis and lymphatic metastasis in breast cancer.A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium.A Novel Role of Cab45-G in Mediating Cell Migration in Cancer CellsInsulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer.STAT3 targets suggest mechanisms of aggressive tumorigenesis in diffuse large B-cell lymphoma.Truncation of histone H2A's C-terminal tail, as is typical for Ni(II)-assisted specific peptide bond hydrolysis, has gene expression altering effectsLymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.The lymphatic system and pancreatic cancer.HIF-2α attenuates lymphangiogenesis by up-regulating IGFBP1 in hepatocellular carcinoma.Corosolic Acid Exhibits Anti-angiogenic and Anti-lymphangiogenic Effects on In Vitro Endothelial Cells and on an In Vivo CT-26 Colon Carcinoma Animal Model.Key architectural changes in tumor-negative lymph nodes from metastatic-free oral cancer patients are valuable prognostic factors.VEGF-C expression is associated with the poor survival in gastric cancer tissue.Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer.Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment
P2860
Q27013620-AE40C683-6531-4BA5-8D98-46399886606DQ28067309-88E1DDCF-AB49-4AD5-9EAC-625B34817894Q33643400-A684AD4B-AA02-48B2-B8D0-0C96E6CD4D17Q33940058-544CBE88-7A38-4120-AA45-A56C21DB32A0Q35584239-B6BEBB8D-A4E0-4009-AA25-628724DAB963Q36911083-0F620B16-29A7-414F-B4D2-437FF3F5060CQ37334160-1119C628-ED4B-4862-A7A7-A6338B38279FQ37366527-0684E6A4-3E6D-4291-9CEC-E1BF648C83F8Q37409379-3989E9D6-19B2-4897-A548-EA63E61B8DBDQ38051085-D72319E3-D087-4DDD-99DE-0977BC01D0EBQ38689578-31D4E967-58FC-42F8-857D-3CCD4269154BQ38901614-8C222C08-8421-4C56-AC8F-D58BF3FADB2AQ38913806-7C2FC20D-67DE-4A56-A8BC-1327F7094780Q44295538-87BCA037-4692-434B-8D52-14FBB1E05D9BQ45802652-3BAFEDEF-F2F3-4D29-9720-5057ED5873F2Q51772676-2039E84C-A19E-4D7E-9BCD-BADEC36B9A54Q54569237-1C4C5DB1-3EED-4CA8-AAD0-8643C7CA203BQ58731258-10589267-D1F7-42DE-B6C3-54A047B1219B
P2860
Tumor lymphangiogenesis and lymphangiogenic growth factors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor lymphangiogenesis and lymphangiogenic growth factors.
@en
Tumor lymphangiogenesis and lymphangiogenic growth factors.
@nl
type
label
Tumor lymphangiogenesis and lymphangiogenic growth factors.
@en
Tumor lymphangiogenesis and lymphangiogenic growth factors.
@nl
prefLabel
Tumor lymphangiogenesis and lymphangiogenic growth factors.
@en
Tumor lymphangiogenesis and lymphangiogenic growth factors.
@nl
P2093
P1476
Tumor lymphangiogenesis and lymphangiogenic growth factors.
@en
P2093
Hong-Wei Tian
Ming-Xu Da
P304
P356
10.1016/J.ARCMED.2007.12.005
P577
2008-03-04T00:00:00Z